Milgamma 100 (Benfotiamine, Pyridoxine Hydrochloride)

Benfotiamine is a lipid‑soluble derivative of thiamine that easily enters cells and is converted to the active cofactor thiamine diphosphate. This cofactor participates in carbohydrate metabolism, helping to reduce harmful glucose‑derived metabolites and protecting nerve cells from oxidative stress.

The appropriate dose of Milgamma 100 is determined by a qualified healthcare professional based on the individual’s clinical condition, age, and nutritional status. Prescribers select the dosage that best matches the therapeutic goal, and patients should follow the specific instructions provided by their clinician.

Safety data for Milgamma 100 in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before starting the supplement.

To place an order, submit an enquiry on the Milgamma 100 product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Milgamma 100 uniquely combines benfotiamine, a highly bioavailable thiamine pro‑drug, with pyridoxine hydrochloride, offering both thiamine and vitamin B6 in a single formulation. Conventional vitamin B1 or B6 tablets may contain water‑soluble forms that have lower cellular uptake, whereas benfotiamine provides enhanced tissue penetration, potentially delivering greater metabolic benefits for nerve health.

Store Milgamma 100 at temperatures below 25 °C in its original container, protecting it from moisture, heat, and direct sunlight. Keep the product out of reach of children and avoid exposing it to excessive humidity, which could affect tablet integrity.

Milgamma 100 is taken orally with a full glass of water. It may be taken with or without food, although some users find it easier on the stomach when taken with meals. Follow the dosing instructions provided by the prescribing clinician.

The most serious risks include severe allergic reactions such as anaphylaxis, rare skin conditions like Stevens‑Johnson syndrome, and significant liver enzyme elevations. If any signs of a serious reaction appear—such as difficulty breathing, widespread rash, or jaundice—medical attention should be sought immediately.

Milgamma 100 should be avoided by individuals with known hypersensitivity to benfotiamine, pyridoxine, or any excipients in the product. It is also contraindicated in patients with severe renal impairment unless supervised by a physician, and it should be used with caution in pregnant or breastfeeding women.